Ipca Laboratories Ltd.

NSE: IPCALAB | BSE: 524494 | ISIN: INE571A01038 | Industry: Pharmaceuticals
| Expensive Performer
1419.0000 -26.70 (-1.85%)
NSE Apr 25, 2025 15:31 PM
Volume: 136.1K
 

logo
Ipca Laboratories Ltd.
14 Aug 2024
1419.00
-1.85%
buy
by Sharekhan
Target: 1600 | Target met
Sharekhan
Ipca Laboratories Limited’s (Ipca) earnings came above our estimates, as sales grew 32.9% y-o-y to Rs. 2,092 crore. Sales growth was led by 11.6% y-o-y growth in domestic branded formulations.
 
Ipca Laboratories Ltd. has an average target of 1815.00 from 3 brokers.
More from Ipca Laboratories Ltd.
Recommended
Five Interesting Stocks Today - April 25, 2025
The Baseline | 25 Apr 2025, 05:30PM
Market closes lower, Maruti Suzuki's Q4 net profit misses Forecaster estimates by 4%
Trendlyne Marketwatch | 25 Apr 2025, 03:56PM
IPCA Labs’ domestic formulations business to drive growth
| 05 Jul 2021